Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 8, 2018
[Advances in the management of cervical lymphadenopathies of unknown primary with intensity modulated radiotherapy: Doses and target volumes]I Troussier, G Klausner, E Blais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 17, 2013
[Brachytherapy training: a survey of French radiation oncology residents]I Fumagalli, J-C Faivre, S Thureau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 15, 2017
[Prophylactic radiotherapy in a single fraction of 10Gy at intervention pleural site in patient with malignant pleural mesothelioma: A retrospective monocentric cohort study]H Carette, J-C Faivre, J Salleron, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 14, 2023
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?J F Py, J Salleron, G Vogin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2021
The Impact of Intra-thoracic Anatomical Changes upon the Delivery of Lung Stereotactic Ablative RadiotherapyS Brown, M Beasley, M C Aznar, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 5, 2015
[Adaptive radiation therapy for non-small cell lung cancer]J-E Bibault, A Arsène-Henry, C Durdux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-upJ Vansteenkiste, L Crinò, C Dooms, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2019
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trialR Y Tay, F Fernández-Gutiérrez, V Foy, et al.
Pageof 14